1 code implementation • 15 Dec 2023 • Hongsong Feng, Sean Cottrell, Yuta Hozumi, Guo-Wei Wei
Single-cell RNA sequencing (scRNA-seq) has emerged as a transformative technology, offering unparalleled insights into the intricate landscape of cellular diversity and gene expression dynamics.
1 code implementation • 24 Oct 2023 • Yuta Hozumi, Guo-Wei Wei
Single-cell RNA sequencing (scRNA-seq) is a relatively new technology that has stimulated enormous interest in statistics, data science, and computational biology due to the high dimensionality, complexity, and large scale associated with scRNA-seq data.
no code implementations • 23 Oct 2023 • Sean Cottrell, Yuta Hozumi, Guo-Wei Wei
We further introduce a k-Nearest-Neighbor (kNN) persistent Laplacian technique to improve the robustness of our persistent Laplacian method.
1 code implementation • 23 Jun 2023 • Yuta Hozumi, Gu-Wei Wei
Single-cell RNA sequencing (scRNA-seq) is widely used to reveal heterogeneity in cells, which has given us insights into cell-cell communication, cell differentiation, and differential gene expression.
no code implementations • 18 Oct 2022 • Jiahui Chen, Rui Wang, Yuta Hozumi, Gengzhuo Liu, Yuchi Qiu, Xiaoqi Wei, Guo-Wei Wei
Accurate and reliable forecasting of emerging dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants enables policymakers and vaccine makers to get prepared for future waves of infections.
2 code implementations • 8 Jun 2022 • Yuta Hozumi, Rui Wang, Guo-Wei Wei
Most dimensionality reduction methods employ frequency domain representations obtained from matrix diagonalization and may not be efficient for large datasets with relatively high intrinsic dimensions.
no code implementations • 9 Sep 2021 • Rui Wang, Jiahui Chen, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
The molecular mechanism underlying such surge is elusive due to 4, 653 non-degenerate mutations on the spike protein, which is the target of most COVID-19 vaccines.
no code implementations • 17 Aug 2020 • Rui Wang, Yuta Hozumi, Yong-Hui Zheng, Changchuan Yin, Guo-Wei Wei
Additionally, we show that children under age five and the elderly may be at high risk from COVID-19 because of their overreacting to the viral infection.
no code implementations • 24 Jul 2020 • Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
Using genotyping, sequence-alignment, time-evolution, $k$-means clustering, protein-folding stability, algebraic topology, and network theory, we reveal that the US SARS-CoV-2 has four substrains and five top US SARS-CoV-2 mutations were first detected in China (2 cases), Singapore (2 cases), and the United Kingdom (1 case).
no code implementations • 2 Jul 2020 • Rui Wang, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
By analyzing the distribution of 11083G>T in various countries, we unveil that 11083G>T may correlate with the hypotoxicity of SARS-CoV-2.
no code implementations • 5 May 2020 • Rui Wang, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
Effective, sensitive, and reliable diagnostic reagents are of paramount importance for combating the ongoing coronavirus disease 2019 (COVID-19) pandemic at a time there is no preventive vaccine nor specific drug available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
no code implementations • 29 Apr 2020 • Rui Wang, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
Tremendous effort has been given to the development of diagnostic tests, preventive vaccines, and therapeutic medicines for coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).